Pfeffer recommends that companies factor people, as well as financial, implications into their management decisions.
FORBES: Stanford's Jeffrey Pfeffer Criticizes Companies For Killing Their Employees
But writing in liberal Israeli newspaper Haaretz, journalist Anshel Pfeffer said the cartoon was "not anti-Semitic by any standard".
Jeffrey Pfeffer of Stanford Business School is an exception to this rule.
ECONOMIST: Why some people have power over companies and others don��t
"Perks and benefits are an indicator of whether or not the organization is building an employee-based culture, but they're not a perfect indicator, " Pfeffer says.
Like Pfeffer, I want to protect individuals from organizational abuse.
FORBES: Stanford's Jeffrey Pfeffer Criticizes Companies For Killing Their Employees
"It's exciting because this is the next big plunge, " says Pfeffer.
The charity agrees with Dr Pfeffer that the screening programme information, which suggests women outside the target age range can request an appointment, can be confusing.
Jeffrey Pfeffer, of Stanford University, studies workplaces extensively and says such added benefits are only useful where there's a positive corporate culture that values employees and rewards their work beyond just food and nap pods.
Harvard researcher Marc Pfeffer, who was paid to help conduct the study for AtheroGenics , said AGI-1067 "is as promising as anything I have seen" for preventing heart attacks on top of existing cholesterol-lowering and hypertension medicines.
Mr Pfeffer points out that CEOs who presided over three years of poor earnings and led their firms into bankruptcy only faced a 50% chance of losing their jobs (and perfectly successful senior managers are routinely cleaned out when new CEOs take over).
ECONOMIST: Why some people have power over companies and others don��t
Harvard researcher Marc Pfeffer, who was paid to help conduct the study for AtheroGenics (nasdaq: AGIX - news - people ), said AGI-1067 "is as promising as anything I have seen" for preventing heart attacks on top of existing cholesterol-lowering and hypertension medicines.
应用推荐